Pembrolizumab for locally advanced cervical cancer.
Schmid MP, Petric P, Mahantshetty U, Kirisits C, Tanderup K, Jürgenliemk-Schulz I, Lindegaard J, Pötter R.
Schmid MP, et al. Among authors: potter r.
Lancet. 2024 Nov 23;404(10467):2050-2051. doi: 10.1016/S0140-6736(24)02231-1.
Lancet. 2024.
PMID: 39580199
No abstract available.